Antiscalant/Scale Inhibitors – By Type (Organic and Inorganic), By Product (Carbonates, Phosphonates, Sulphates, Fluorides and Others), By Method (Threshold Inhibition, Crystal Modification and Dispersion), By End User (Oil & Gas, Mining, Water Treatment, Pharmaceutical, Agriculture, Chemical Industry, Food & Beverage, Power Generation and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2023-2030

Report Code: CMR 1437 Report Format: PDF + Excel

Antiscalant/Scale Inhibitors Overview:

Antiscalant/Scale Inhibitors size is estimated to reach US$4.7 billion by 2030, growing at a CAGR of 4.7% during the forecast period 2024-2030. Technological advancements in antiscalant formulations and the growing demand for water treatment are driving the demand for antiscalants. This trend is expected to boost the growth of the Antiscalant/Scale Inhibitors during the forecast period.
 
Additionally, emerging economies are experiencing rapid industrialization and urbanization, leading to a significant increase in demand for water treatment solutions. This presents an opportunity for antiscalant manufacturing companies to expand their market reach and increase sales in these regions. This boosts the Antiscalant industry outlook during the forecast period.

Market Snapshot: 

                                       Image
 

Antiscalant/Scale Inhibitors - Report Coverage:

The “Antiscalant/Scale Inhibitors Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Antiscalant/Scale Inhibitors.
 
                 Attribute                         Segment

By Type

  • Organic

  • Inorganic
 

By Product

  • Carbonates

  • Phosphonates

  • Sulphates

  • Fluorides

  • Others
 

By Method

 

  • Threshold Inhibition

  • Crystal Modification

  • Dispersion



 

By End User

  • Oil & Gas

  • Mining

  • Water Treatment

  • Pharmaceutical

  • Agriculture

  • Chemical Industry

  • Food & Beverage

  • Power Generation

  • Others



 

By Geography

  • North America (U.S., Canada and Mexico)

  • Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe),

  • Asia-Pacific (China, Japan, South Korea, India, Taiwan and Rest of Asia-Pacific),

  • South America (Brazil, Argentina, Colombia and Rest of South America)

  • Rest of the World (Middle East and Africa).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COVID-19 / Ukraine Crisis - Impact Analysis:  

  • The COVID-19 pandemic impacted the operations of various industries globally. As a result, several industries such as chemical and oil & gas had to shut down production as countries adopted partial or absolute lockdown policies to deal with the pandemic. Companies throughout the world also halted or postponed large oil and gas ventures. The decline in production activities further negatively affected the demand for antiscalants over the short to medium term.
  • Like most chemicals, antiscalants are subject to price volatility due to various factors such as energy prices, transportation costs, and currency exchange rates. The Russia-Ukraine war has had a direct impact on the price of oil & gas as Russia is a major supplier. Western sanctions also have impacted the oil price. On February 24, 2022, when US President Biden, announced sanctions against Russia, West Texas Intermediate (WTI) crude rose 0.8%, to settle at US$92.81 a barrel, after earlier rising to US$100.54. WTI hit its highest levels since July 2012.  This uncertainty has also contributed to fluctuations in antiscalant prices amid a complex geopolitical situation.

Key Takeaways:

Fastest Growth of Asia-Pacific Region

Geographically, in the Antiscalant/Scale Inhibitors share, Asia-Pacific is analyzed to grow with the highest CAGR of 6.2% during the forecast period 2023-2030. APAC has a rising need for antiscalants owing to the growth of the chemical sector, the expansion of oil and gas production, and the accessibility of cheap labor. According to Invest India, the market for chemicals and petrochemicals is anticipated to reach $300 billion by 2025. Antiscalant demand will thus increase as a result of the expanding chemical industry. The region is also home to several major industries that require significant amounts of water, such as power generation, mining, and chemical manufacturing, which are all users of antiscalants.

Phosphonate Segment to Hold the Largest Market Share

In the Antiscalant/Scale Inhibitors analysis, the phosphonate segment is estimated to hold the largest market share in 2022 as it is widely used for water treatment solutions using corrosion and scale inhibitors, as well as iron sequestrants. By integrating multiple functions in one molecule, phosphonates provide efficacy at low concentrations. These are also utilized in the manufacture of bleaching agents as a stabilizer. Phosphonates antiscalants are oxidized by hydrogen peroxide and ozone. Higher phosphonate oxidation results from the coordination of the phosphonate with dissolved calcium ions. Sulfonates also held a significant share and, owing to their growing use in the seawater treatment sector. For the desalination of seawater resulting in precipitation, sulfonates are commonly used. This has contributed to its rising penetration in the sector of seawater treatment. Offshore oil and gas facilities that require antiscalants for seawater desalination have also experienced an increase in demand.

Water Treatment is the Fastest Growing Segment

According to the Antiscalant/Scale Inhibitors forecast, the water treatment segment is estimated to grow with a CAGR of 6.2% during the forecast period. Antiscalant is the preferred pretreatment method for water systems due to its unmatched effectiveness in reducing membrane fouling. When used properly, antiscalant extends the time between membrane cleanings from a few weeks to years in some cases. In August 2023, LG Chem announced that it will invest approx. US$97.9 million by July 2025 to expand its Cheongju plant by adding a facility capable of producing 400,000 RO membranes annually. The planned expansion will desalinate 1.57 billion tons (4.32 million tons per day) of water annually. This water can be used by approximately 16 million people, which is about one-third of the entire Korean population. With the growing threat of water scarcity, there is a growing demand for water treatment solutions which fuels the growth of the Antiscalant/Scale Inhibitors.

Technological Advancements in Antiscalant Formulations

The development of new and more effective antiscalant formulations is driving the growth of the Antiscalant/Scale Inhibitors. Technological advancement leads to the new formulations that are more effective at preventing scaling and fouling while being environmentally friendly and cost-effective are expected to drive the growth of the Antiscalant/Scale Inhibitors in the coming years. The popularity of smart antiscalants, that use sensors to detect scaling and adjust the dosage of antiscalant accordingly, is growing. Smart antiscalants reduce waste and improves efficiency. In January 2023, Perm Ionics and Grundfos collaborated on implementing the Smart Filtration Suite, specifically the SmartRO algorithm focused on optimizing antiscalant dosing. Its main features include a unified data normalization analytic control as well as an antiscalant controller and optimizer that runs in auto mode.

Increasing Demand for Water Treatment

Water scarcity is becoming an increasingly pressing issue in many parts of the world. Antiscalants are used in desalination plants to prevent scaling and fouling of equipment, making them essential in areas where freshwater resources are limited. According to Asian Development Bank report published in 2022, despite advances in the water sector of the Asia and Pacific region, almost 500 million people in the Asia and Pacific region do not have access to basic water supplies and 1.12 billion lack access to basic sanitation. Moreover, the government are investing in water and wastewater management. In October 2023, the International Finance Corporation (IFC) and Thailand's Ministry of Interior signed a memorandum of understanding (MoU) to improve access to quality water and expand the country's wastewater treatment capacity. In March 2022, the Singapore Government allocated $220 million under the Research, Innovation and Enterprise 2025 (RIE2025) Urban Solutions & Sustainability (USS) domain to drive new initiatives in water technologies and resource circularity. Such investments will boost the demand for antiscalants and drive market growth during the forecast period.

Environmental Issues to Impede to Market growth

Despite the essential efficacy of antiscalants, their use is increasingly correlated with many operational and environmental issues, such as membrane fouling of antiscalants and enhancing the formation of biofilm. Concentrated streams of rejected antiscalant compounds are often released into the water bodies and there are still uncertain acute and long-term effects on marine and aquatic environments. Therefore, these factors may restrain Antiscalant/Scale Inhibitors growth. In addition, the growing concern about the use of inorganic substances, especially in the food industry, is expected to be another limiting factor for the demand for organic antiscalants. Further treatment of traces in food and beverage products, resulting in additional cost increases, could lead to a restriction of the Antiscalant/Scale Inhibitors.
 

Antiscalant/Scale Inhibitors Share (%) By Region, 2022

  

 For More Details on This Report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Antiscalant/Scale Inhibitors. The top 10 companies in this industry are listed below:
  1. BASF SE
  2. The Dow Chemical Company
  3. Kemira Oyj
  4. Clariant AG
  5. Solvay S.A.
  6. Ashland Global Speciality Chemicals Inc.
  7. SNF
  8. Italmatch
  9. Solenis
  10. Avista

Scope of Report: 

Report Metric Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

4.7%

Market Size in 2030

$4.7 billion

Segments Covered

Type, Product, Method, End User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Taiwan and Rest of Asia-Pacific), South America (Brazil, Argentina, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players
  1. BASF SE
  2. The Dow Chemical Company
  3. Kemira Oyj
  4. Clariant AG
  5. Solvay S.A.
  6. Ashland Global Speciality Chemicals Inc.
  7. SNF
  8. Italmatch
  9. Solenis
  10. Avista

 
 
For more Chemicals and Materials Market reports, please click here
1. Antiscalant/Scale Inhibitors- Overview
    1.1. Definitions and Scope
2. Antiscalant/Scale Inhibitors- Executive Summary
3. Antiscalant/Scale Inhibitors- Comparative Analysis
    3.1. Company Benchmarking - Key Companies
    3.2. Global Financial Analysis - Key Companies
    3.3. Market Share Analysis - Key Companies
    3.4. Patent Analysis
    3.5. Pricing Analysis
4. Antiscalant/Scale Inhibitors- Start-up Companies Scenario
    4.1. Key Start-up Company Analysis by
        4.1.1. Investment
        4.1.2. Revenue
        4.1.3. Venture Capital and Funding Scenario
5. Antiscalant/Scale Inhibitors– Market Entry Scenario Premium
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. Antiscalant/Scale Inhibitors- Forces
    6.1. Market Drivers
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
        6.4.1. Bargaining Power of Suppliers
        6.4.2. Bargaining Powers of Customers
        6.4.3. Threat of New Entrants
        6.4.4. Rivalry Among Existing Players
        6.4.5. Threat of Substitutes
7. Antiscalant/Scale Inhibitors– Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. Antiscalant/Scale Inhibitors– by Type (Market Size – $Million/$Billion) 
    8.1. Organic
    8.2. Inorganic
9. Antiscalant/Scale Inhibitors– by Product (Market Size – $Million/$Billion) 
    9.1. Carbonates
    9.2. Phosphonates
    9.3. Sulphates 
    9.4. Fluorides 
    9.5. Others
10. Antiscalant/Scale Inhibitors- By Method (Market Size – $Million/$Billion)
    10.1. Threshold Inhibition
    10.2. Crystal Modification
    10.3. Dispersion
11. Antiscalant/Scale Inhibitors- By End User (Market Size – $Million/$Billion)
    11.1. Oil & Gas 
    11.2. Mining 
    11.3. Water Treatment 
    11.4. Pharmaceutical 
    11.5. Agriculture 
    11.6. Chemical Industry 
    11.7. Food & Beverage 
    11.8. Power Generation 
    11.9. Others 
12. Antiscalant/Scale Inhibitors– by Geography (Market Size – $Million/$Billion) 
    12.1. North America
        12.1.1. U.S.
        12.1.2. Canada
        12.1.3. Mexico
    12.2. Europe
        12.2.1. U.K.
        12.2.2. Germany
        12.2.3. France
        12.2.4. Italy
        12.2.5. Spain
        12.2.6. Russia
        12.2.7. Rest of Europe
    12.3. Asia-Pacific
        12.3.1. China
        12.3.2. Japan
        12.3.3. South Korea
        12.3.4. India
        12.3.5. Taiwan
        12.3.6. Rest of Asia-Pacific
    12.4. South America
        12.4.1. Brazil
        12.4.2. Argentina
        12.4.3. Colombia
        12.4.4. Others
    12.5. Rest of the World
        12.5.1. Middle East
        12.5.2. Africa
13. Antiscalant/Scale Inhibitors– Entropy
    13.1 New product launches
    13.2 M&A’s, collaborations, JVs and partnerships
14. Antiscalant/Scale Inhibitors– Industry/Segment Competition Landscape 
    14.1. Market Share Analysis
        14.1.1. Market Share by Region – Key companies
        14.1.2. Market Share by Countries – Key Companies
    14.2. Competition Matrix
    14.3. Best Practices for Companies
15. Antiscalant/Scale Inhibitors– Key Company List by Country Premium 
16. Antiscalant/Scale Inhibitors- Company Analysis
    16.1 BASF SE
    16.2 The Dow Chemical Company
    16.3 Kemira Oyj
    16.4 Clariant AG
    16.5 Solvay S.A.
    16.6 Ashland Global Speciality Chemicals Inc.
    16.7 SNF
    16.8 Italmatch
    16.9 Solenis
    16.10 Avista
 
"Financials to the Private Companies would be provided on best-effort basis."
 
Connect with our experts to get customized reports that best suit your requirements. Our 
reports include global-level data, niche markets and competitive landscape.

The Antiscalant/Scale Inhibitors is projected to grow at a CAGR of 4.7% during the forecast period 2023-2030.

Global Antiscalant/Scale Inhibitors size is estimated to be $3.3 billion in 2022 and is projected to reach $4.7 billion by 2030.

The leading players in the Antiscalant/Scale Inhibitors are BASF SE, Dow, Veolia, Kemira, Kurita Water Industries and others.

Demand from emerging economies and the growing demand of antiscalant from mining and power generation industry are some of the major Antiscalant trends in the industry which will create growth opportunities for the market during the forecast period.

Technological advancements in antiscalant formulations and the growing demand for water treatment are the driving factors of the market.